MedPath

EMTRICITABINA/TENOFOVIR DISOPROXILO AUROVITAS 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

EMTRICITABINA/TENOFOVIR DISOPROXILO AUROVITAS 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Commercialized
Register Number

84875

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Apr 17, 2020

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number84875
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (2)

EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR DISOPROXILO FUMARATOActive
Quantity: 300 mg
Name: TENOFOVIR DISOPROXILO FUMARATO

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.